chr19-9960653-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The ENST00000264828.4(COL5A3):ā€‹c.5089C>Gā€‹(p.Arg1697Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000062 ( 0 hom. )

Consequence

COL5A3
ENST00000264828.4 missense, splice_region

Scores

4
15
Splicing: ADA: 0.0004214
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0970
Variant links:
Genes affected
COL5A3 (HGNC:14864): (collagen type V alpha 3 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are thought to be responsible for the symptoms of a subset of patients with Ehlers-Danlos syndrome type III. Messages of several sizes can be detected in northern blots but sequence information cannot confirm the identity of the shorter messages. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28077668).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL5A3NM_015719.4 linkuse as main transcriptc.5089C>G p.Arg1697Gly missense_variant, splice_region_variant 66/67 ENST00000264828.4 NP_056534.2
COL5A3XM_011528042.3 linkuse as main transcriptc.5086C>G p.Arg1696Gly missense_variant, splice_region_variant 66/67 XP_011526344.1
COL5A3XM_017026849.2 linkuse as main transcriptc.2752C>G p.Arg918Gly missense_variant, splice_region_variant 39/40 XP_016882338.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL5A3ENST00000264828.4 linkuse as main transcriptc.5089C>G p.Arg1697Gly missense_variant, splice_region_variant 66/671 NM_015719.4 ENSP00000264828 P1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000160
AC:
4
AN:
250748
Hom.:
0
AF XY:
0.0000148
AC XY:
2
AN XY:
135580
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000616
AC:
9
AN:
1461598
Hom.:
0
Cov.:
40
AF XY:
0.00000550
AC XY:
4
AN XY:
727122
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000134
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.0000189
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 25, 2024The c.5089C>G (p.R1697G) alteration is located in exon 66 (coding exon 66) of the COL5A3 gene. This alteration results from a C to G substitution at nucleotide position 5089, causing the arginine (R) at amino acid position 1697 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
18
DANN
Benign
0.93
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.16
N
LIST_S2
Uncertain
0.91
D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.28
T
MetaSVM
Benign
-0.62
T
MutationAssessor
Uncertain
2.3
M
MutationTaster
Benign
0.97
N
PrimateAI
Benign
0.28
T
PROVEAN
Uncertain
-2.5
N
REVEL
Benign
0.25
Sift
Benign
0.077
T
Sift4G
Benign
0.081
T
Polyphen
0.81
P
Vest4
0.25
MutPred
0.52
Gain of ubiquitination at K1700 (P = 0.037);
MVP
0.68
MPC
0.45
ClinPred
0.63
D
GERP RS
0.28
Varity_R
0.43
gMVP
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00042
dbscSNV1_RF
Benign
0.064
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs568686157; hg19: chr19-10071329; COSMIC: COSV53410819; API